Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Goulden T, Stout AP. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet 1941;73:784–8.
Welsh RA, Meyer AT. Ultrastructure of gastric leiomyoma. Arch Pathol Lab Med 1969;87:71–81.
Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507–19.
Appelman HD. Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn’t know. Am J Surg Pathol 1986;10(Suppl 1):83–99.
Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259–69.
Chan JK. Mesenchymal tumors of the gastrointestinal tract: a paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-KIT in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases? Adv Anat Pathol 1999; 6:19–40.
Erlandson RA, Klimstra DS, Woodruff JM. Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol 1996;20:373–93.
Rumessen JJ, Thuneberg L. Pacemaker cells in the gastrointestinal tract: interstitial cells of Cajal. Scand J Gastroenterol Suppl 1996;216:82–94.
Wester T, Eriksson L, Olsson Y, Olsen L. Interstitial cells of Cajal in the human fetal small bowel as shown by c-KIT immunohistochemistry. Gut 1999;44:65–71.
Torihashi S, Nishi K, Tokutomi Y et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype. Gastroenterology 1999;117:140–8.
Kitamura Y, Hirota S, Nishida T. Molecular pathology of c-KIT proto-oncogene and development of gastrointestinal stromal tumors. Ann Chir Gynaecol 1998;87:282–6.
Lasota J, Wozniak A, Sarlomo-Rikala M et al. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am J Pathol 2000;157:1091–5.
Sakurai S, Hishima T, Takazawa Y et al. Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum. Pathol Int 2001; 51:524–31.
Walker P, Dvorak AM. Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity. Arch Pathol Lab Med 1986; 110:309–16.
Herrera GA, Cerezo L, Jones JE et al. Gastrointestinal autonomic nerve tumors. ‘Plexosarcomas’. Arch Pathol Lab Med 1989;113:846–53.
Rosen RM. Familial multiple upper gastrointestinal leiomyoma. Am J Gastroenterol 1990;85:303–5.
Clary BM, DeMatteo RP, Lewis JJ et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001;8:290–9.
Miettinen M, Lasota J. Gastrointestinal stromal tumors — definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1–12.
Hansson LE, Sparen P, Nyren O. Stomach leiomyosarcoma: secular trends in incidence and survival in Sweden, 1960–1989. Scand J Gastroenterol 1998;33:540–3.
Chow JS, Chen CC, Ahsan H, Neugut AI. A populationbased study of the incidence of malignant small bowel tumours: SEER, 1973–1990. Int J Epidemiol 1996;25:722–8.
Karnak I, Senocak ME, Ciftci AO et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg 2001;36:908–12.
Kim IH, Kim PS, Lee DH et al. Gastric malignant stromal tumor with long stalk impacted into duodenum. Yonsei Med J 1999;40:510–3.
Shojaku H, Futatsuya R, Seto H et al. Malignant gastrointestinal stromal tumor of the small intestine: radiologic-pathologic correlation. Radiat Med 1997;15:189–92.
Hama Y, Okizuka H, Odajima K et al. Gastrointestinal stromal tumor of the rectum. Eur Radiol 2001;11:216–9.
Tworek JA, Appelman HD, Singleton TP, Greenson JK. Stromal tumors of the jejunum and ileum. Mod Pathol 1997;10:200–9.
Joensuu H, Roberts PJ, Sarlomo-Rikala M et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052–6.
Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472–80.
DeMatteo RP, Lewis JJ, Leung D et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–8.
Emory TS, O’Leary TJ. Prognosis and surveillance of gastrointestinal stromal/smooth muscle tumors. Ann Chir Gynaecol 1998;87:306–10.
Franquemont DW, Frierson HF Jr. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod Pathol 1995;8:473–7.
Ueyama T, Guo KJ, Hashimoto H et al. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992;69:947–55.
Emory TS, Sobin LH, Lukes L et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999;23:82–7.
Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160–5.
Cunningham RE, Abbondanzo SL, Chu WS et al. Apoptosis, bcl-2 expression, and p53 expression in gastrointestinal stromal/smooth muscle tumors. Appl Immunohistochem Mol Morphol 2001;9:19–23.
Ernst SI, Hubbs AE, Przygodzki RM et al. KIT mutation portends poor prognosis in gastrointestinal stromal/ smooth muscle tumors. Lab Invest 1998;78:1633–6.
Berman J, O’Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001;32:578–82.
DeMatteo RP, Lewis JJ, Leung D et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–8.
Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995;103:41–7.
Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001;54:96–102.
Joensuu H, Fletcher C, Dimitrijevic S et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002;3:655–64.
Miettinen M, Lasota J. Gastrointestinal stromal tumors — definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1–12.
Savage DG, Antman KH. Imatinib mesylate — a new oral targeted therapy. N Engl J Med 2002;346:683–93.
Tworek JA, Appelman HD, Singleton TP, Greenson JK. Stromal tumors of the jejunum and ileum. Mod Pathol 1997;10:200–9.
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Samel, S.T., Post, S. (2005). Stromal Upper GI Tract Neoplasms. In: Upper Gastrointestinal Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/1-84628-066-4_15
Download citation
DOI: https://doi.org/10.1007/1-84628-066-4_15
Publisher Name: Springer, London
Print ISBN: 978-1-85233-607-3
Online ISBN: 978-1-84628-066-5
eBook Packages: MedicineMedicine (R0)